Advertisement

The Scientist

» FDA, developmental biology and microbiology

Most Recent

image: SPRead Your Antibody Capabilities

SPRead Your Antibody Capabilities

By | May 1, 2012

Using surface plasmon resonance to improve antibody detection and characterization: four case studies

0 Comments

image: Call for Diabetes Drug Ban

Call for Diabetes Drug Ban

By | April 30, 2012

A consumer advocacy group calls for a ban of a diabetes drug after evidence surfaces that it may increase the risk of cancer.

0 Comments

image: Ants Share Pathogens for Immunity

Ants Share Pathogens for Immunity

By | April 3, 2012

A new study shows that grooming by ants promotes colony-wide resistance to fungal infections by transferring small amounts of pathogen to nestmates.

8 Comments

image: US Doesn’t Ban BPA

US Doesn’t Ban BPA

By | April 2, 2012

The FDA announces that BPA will continue to be permitted in food and beverage containers.

4 Comments

image: Obesity Drugs in Check

Obesity Drugs in Check

By | April 2, 2012

The FDA may require weight-loss drugs to undergo clinical trials to see if they pose a risk of heart attack.

2 Comments

image: The Two Faces of Metastasis

The Two Faces of Metastasis

By | April 1, 2012

During development, the cells of an embryo change their pattern of gene expression, which allows them to detach from their original location and migrate to another part of the embryo, where the pattern changes again to allow formation of a new organ.

0 Comments

image: Are Cancer Stem Cells Ready for Prime Time?

Are Cancer Stem Cells Ready for Prime Time?

By | April 1, 2012

A flood of new discoveries has refined our definition of cancer stem cells. Now it’s up to human clinical trials to test if they can make a difference in patients.

48 Comments

image: More Oversight for Omics Tests

More Oversight for Omics Tests

By | March 27, 2012

A new report outlines ways in which omics-based technologies can be shuttled more safely and effectively from the bench to the clinic.

0 Comments

image: A FASTer FDA?

A FASTer FDA?

By | March 19, 2012

A new bill recently debated in the US Congress seeks to streamline the approval process for drugs.

0 Comments

image: Slipping from the Top?

Slipping from the Top?

By | March 14, 2012

Experts and the American public worry that the country is at risk of losing its global leadership position in scientific research.

24 Comments

Follow The Scientist

icon-facebook icon-linkedin icon-twitter icon-vimeo icon-youtube
Advertisement

Stay Connected with The Scientist

  • icon-facebook The Scientist Magazine
  • icon-facebook The Scientist Careers
  • icon-facebook Neuroscience Research Techniques
  • icon-facebook Genetic Research Techniques
  • icon-facebook Cell Culture Techniques
  • icon-facebook Microbiology and Immunology
  • icon-facebook Cancer Research and Technology
  • icon-facebook Stem Cell and Regenerative Science
Advertisement
Advertisement
Mettler Toledo
BD Biosciences
BD Biosciences